Skip to content

Opening book details…

Can I read Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM on EtoBox?

Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM by Yuji Kawaguchi; Shoko Miyamoto; Yuriko Hajika; Narumi Ashida; Tomoe Hirota; Koji Masumoto; Jun Sawa; Kenji Hamazaki; Yasuro Kumeda is a Medicine article available to read on EtoBox.

What is Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM about?

## Introduction We aimed to compare the efficacy of insulin degludec/insulin aspart (IDegAsp) and insulin degludec/liraglutide (IDegLira) in controlling glucose fluctuation and suppressing postprandial glucose levels using intermittently scanned continuous glucose monitoring. ## Methods Twenty-four patients with type 2 diabetes mellitus were randomly allocated to receive either IDegLira or IDegAsp followed by IDegAsp or IDegLira, respectively. A crossover study was conducted with intermittently scanned continuous glucose monitoring. We compared the postprandial blood glucose level, time in range, and time below range from a 3-day intermittently scanned continuous glucose monitoring period for each treatment group. ## Results The time in range was significantly higher in IDegLira than in IDegAsp. Postprandial glucose levels 90 and 120 min after breakfast and 60, 90, and 120 min after lunch were significantly lower for IDegLira than for IDegAsp. However, postprandial glucose levels 90 and 120 min after supper were significantly lower for IDegAsp than for IDegLira. There was no significant difference in the time below range between IDegLira and IDegAsp. ## Conclusion IDegLira was more

Who reads Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Yuji Kawaguchi; Shoko Miyamoto; Yuriko Hajika; Narumi Ashida; Tomoe Hirota; Koji Masumoto; Jun Sawa; Kenji Hamazaki; Yasuro Kumeda
Publisher
Springer Science and Business Media LLC
Published
2022
Language
EN
Field
Medicine (Health Sciences)

More by Yuji Kawaguchi; Shoko Miyamoto; Yuriko Hajika; Narumi Ashida; Tomoe Hirota; Koji Masumoto; Jun Sawa; Kenji Hamazaki; Yasuro Kumeda

Browse all works by Yuji Kawaguchi; Shoko Miyamoto; Yuriko Hajika; Narumi Ashida; Tomoe Hirota; Koji Masumoto; Jun Sawa; Kenji Hamazaki; Yasuro Kumeda